Eric Rhodes & Dr. Jon Moore
Articles by Eric Rhodes & Dr. Jon Moore

| 6 min read
The ability to create
isogenic cell lines in which the genome editing event is the sole differentiator between the phenotypes of two cells is a powerful tool. Despite all the
recent developments and improvements in targeting platforms, certain challenges remain, and the role played by the choice of cell line in order to achieve
success cannot be overstated.
Page 1 of 1 - 1 Total Items


Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe